Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. Keeping that in mind, here are three stocks likely to meet or exceed Wall Street’s lofty expectations.
Toast (TOST)
Consensus Price Target: $38.92 (26.7% implied return)
Born from the frustrations of three friends waiting too long for their restaurant bill, Toast (NYSE:TOST) provides a cloud-based digital technology platform with software, payment processing, and hardware solutions built specifically for restaurants.
Why Could TOST Be a Winner?
- Ability to secure long-term commitments with customers is evident in its 26.5% ARR growth over the last year
- Projected revenue growth of 19.9% for the next 12 months suggests its momentum from the last two years will persist
Toast’s stock price of $30.73 implies a valuation ratio of 2.3x forward price-to-sales. Is now a good time to buy? Find out in our full research report, it’s free.
Interface (TILE)
Consensus Price Target: $45.25 (31.6% implied return)
Pioneering carbon-neutral flooring since its founding in 1973, Interface (NASDAQ:TILE) is a global manufacturer of modular carpet tiles, luxury vinyl tile (LVT), and rubber flooring that specializes in carbon-neutral and sustainable flooring solutions.
Why Do We Like TILE?
- Performance over the past two years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 34.1% outpaced its revenue gains
- Free cash flow margin jumped by 7.5 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
- Returns on capital are climbing as management makes more lucrative bets
At $34.38 per share, Interface trades at 1.4x trailing 12-month price-to-sales. Is now the right time to buy? See for yourself in our full research report, it’s free.
Stryker (SYK)
Consensus Price Target: $374.28 (32.6% implied return)
With over 150 million patients impacted annually through its innovative healthcare technologies, Stryker (NYSE:SYK) develops and manufactures advanced medical devices and equipment across orthopedics, surgical tools, neurotechnology, and patient care solutions.
Why Are We Fans of SYK?
- Core business is healthy and doesn’t need acquisitions to boost sales as its organic revenue growth averaged 9.2% over the past two years
- Economies of scale give it more fixed cost leverage than its smaller competitors
- Free cash flow margin grew by 6.5 percentage points over the last five years, giving the company more chips to play with
Stryker is trading at $282.28 per share, or 17.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.